Aptevo Therapeutics Inc. (APVO)
NASDAQ: APVO · Real-Time Price · USD
3.470
+0.060 (1.76%)
At close: Feb 21, 2025, 4:00 PM
3.310
-0.160 (-4.61%)
After-hours: Feb 21, 2025, 5:57 PM EST
Aptevo Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Feb '25 Feb 21, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Market Capitalization | 5 | 2 | 3 | 12 | 39 | 160 | |
| Market Cap Growth | -36.76% | -36.76% | -71.13% | -69.35% | -75.98% | 441.56% | |
| Enterprise Value | 2 | -0 | -10 | -0 | 6 | 164 | |
| Last Close Price | 3.47 | 4.31 | 294.67 | 3776.96 | 12812.36 | 59666.19 | |
| PE Ratio | - | - | - | 1.47 | - | - | |
| PS Ratio | - | - | - | 3.79 | 3.14 | 37.23 | |
| PB Ratio | 1.06 | 0.45 | 0.28 | 0.66 | 31.69 | 9.67 | |
| P/TBV Ratio | 0.45 | 0.45 | 0.28 | 0.66 | 31.69 | 9.67 | |
| EV/Sales Ratio | - | - | - | - | 0.47 | 38.02 | |
| Debt / Equity Ratio | 1.14 | 1.14 | 0.44 | 0.55 | 13.75 | 1.65 | |
| Asset Turnover | - | - | - | 0.07 | 0.22 | 0.08 | |
| Quick Ratio | 1.40 | 1.40 | 2.34 | 2.89 | 1.40 | 2.91 | |
| Current Ratio | 1.72 | 1.72 | 2.64 | 3.15 | 1.51 | 3.25 | |
| Return on Equity (ROE) | -284.28% | -284.28% | -123.53% | 73.10% | -330.24% | -217.49% | |
| Return on Assets (ROA) | -76.06% | -76.06% | -61.12% | -39.42% | -24.29% | -32.13% | |
| Return on Capital (ROIC) | -110.74% | -110.74% | -79.25% | -78.06% | -43.19% | -43.48% | |
| Earnings Yield | -476.80% | -1118.99% | -510.60% | 67.96% | -73.84% | -11.06% | |
| FCF Yield | -469.98% | -1102.99% | -344.00% | -178.24% | -58.10% | -18.33% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.